Aims Lung metastasectomy and, more recently, stereotactic body radiotherapy (SBRT), are
frequently proposed to stage IV oligometastatic colorectal cancer (CRC) patients. In the …

Purpose The current oligometastatic (OM) model postulates that the disease evolves
dynamically with sequential emergence of OM (SOM) lesions requiring successive rounds of …

Oligometastasis refers to a state of limited metastatic disease burden, in which surgical or
ablative treatment to all known visible metastases holds promise to extend survival or even …

Background For oligometastatic lung adenocarcinoma patients with sensitive epidermal
growth factor receptor (EGFR) mutations, the role of local consolidative therapy (LCT) …

Prostate cancer is a heterogeneous cancer with widely varying levels of morbidity and
mortality. Approaches to prostate cancer screening, diagnosis, surveillance, treatment and …

With the development of systemic treatments with high response rates, including tyrosine
kinase inhibitors and immune checkpoint inhibitors, some patients with unresectable lung …

Purpose To analyse the prognostic impact on overall survival (OS) of single versus multiple
organ metastases, organ affected, and local disease status in a population based stage IV …

To obtain a favorable tradeoff between treatment benefits and morbidity (“therapeutic ratio”),
radiotherapy (RT) dose is prescribed according to the tumor volume, with the goal of …

Non-small cell lung cancer (NSCLC) typically presents at an advanced stage, which is often
felt to be incurable, and such patients are usually treated with a palliative approach …

Objective In this review, we aim to summarize the most recent data on the surgical
management of oligometastatic non-small cell lung cancer (NSCLC). Background …